COVID-19 risk and effect modification by vaccination in asthma - Vienna 2024

Determinants, diagnosis, incidence and management of respiratory health in populations

Chair(s): Om Prakash Kurmi, Rita Amaral

Session type: Oral presentation

COVID-19 risk and effect modification by vaccination in asthma

Brian Kirui

EVENTS HOME

Previous presentation

Next presentation

Session content

Late Breaking Abstract - Early-life antibiotic exposure and development of diseases in childhood - a nationwide registry study

Sarah Brandt

Replay

Poster

Abstract

Slides

Recurrent respiratory infections and allergy hallmarks at-risk progression to severe asthma

Emilie Johanning Bari

Replay

Abstract

Slides

The effect of health disparities on racial gaps in lung function

Amin Adibi

Replay

Poster

Abstract

Slides

Small airways obstruction and mortality in the UK Biobank

Valentina Quintero Santofimio

Replay

Poster

Abstract

Slides

COVID-19 risk and effect modification by vaccination in asthma

Brian Kirui

Replay

Poster

Abstract

Slides

Low smoking exposure and development and prognosis of COPD over four decades: A population-based cohort study

Yunus ?olak

Replay

Poster

Abstract

Slides

CC16 as a mediator of the effects of preterm birth on airflow limitation and asthma: a longitudinal study from birth to adult life

Nipasiri Voraphani

Replay

Poster

Abstract

Slides

Influence of pregnancy on asthma exacerbation patterns: a UK population-based cohort

Chloe Bloom

Replay

Poster

Abstract

Slides

Trends in the initial treatment of adults with asthma in the Netherlands: a population-based database study

Joana Ant

Replay

Poster

Abstract

Slides

Asthma and reproductive outcomes: A Danish nationwide cohort study

Anne Vejen Hansen

Replay

Poster

Abstract

Slides

Discussion and Q&A

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}